News & Analysis on Clinical Trial Services & Contract Research And Development
Elligo Health Research
By Melissa Fassbender
- Last updated on
The clinical research infrastructure provider has named Deirdre BeVard as chief operating officer.
BeVard has held several leadership roles in clinical affairs and development operations over the past 25 years.
"I’ve been looking for an opportunity that focuses on expanding clinical trial access beyond the small percentage of physicians and patients that have access to research today," BeVard told us.
Before joining Elligo, she was vice president of development of Nektar Therapeutics.
“BeVard’s experience and passion for creating clinical trial efficiencies perfectly align with our core mission,” John Potthoff, Ph.D., CEO of Elligo Health Research commented in a press release. “Through her analysis and fostering of productive stakeholder relationships, she will create environments that enhance the clinical trial process for sponsors, physicians and patients.”